Antileishmanial activity of 5-nitroindazole derivatives
Background: Currently, there is no safe and effective vaccine against leishmaniasis and existing therapies are inadequate due to high toxicity, cost and decreased efficacy caused by the emergence of resistant parasite strains. Some indazole derivatives have shown in vitro and in vivo activity agains...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-10-01
|
Series: | Therapeutic Advances in Infectious Disease |
Online Access: | https://doi.org/10.1177/20499361231208294 |